TFLLR-NH2(TFA)

TFLLR-NH2(TFA), also known as Thrombin Receptor Activating Peptide-6 amide trifluoroacetate, is a synthetic hexapeptide that serves as a potent and selective agonist for the protease-activated receptor-1 (PAR-1). Characterized by its specific amino acid sequence, TFLLR-NH2(TFA) is widely utilized in research environments to mimic the action of thrombin on cellular receptors without the complexity or variability associated with using native thrombin. Its amide and trifluoroacetate modifications enhance its stability and solubility, making it a reliable tool for in vitro studies. By precisely targeting PAR-1, this peptide allows researchers to dissect intricate signaling pathways with high specificity and reproducibility, supporting a broad spectrum of experimental designs in cellular and molecular biology.

Platelet Activation Studies: TFLLR-NH2(TFA) is extensively employed in platelet biology to investigate the mechanisms underlying platelet activation and aggregation. By selectively activating PAR-1 on platelets, it provides a controlled system to study intracellular signaling cascades, granule secretion, and cytoskeletal rearrangements. Researchers leverage this peptide to delineate the roles of specific G-protein-coupled receptor pathways in hemostasis and thrombosis, which is pivotal for understanding platelet function and the development of antithrombotic agents. Its use circumvents the pleiotropic effects of thrombin, enabling a focused analysis of PAR-1-mediated responses in both isolated platelets and complex blood samples.

Vascular Endothelial Cell Research: In vascular biology, TFLLR-NH2(TFA) facilitates the exploration of endothelial cell responses to PAR-1 activation, such as changes in permeability, inflammatory mediator release, and cytoskeletal dynamics. By applying this peptide to cultured endothelial cells, scientists can dissect the contribution of PAR-1 to vascular inflammation, barrier function, and angiogenesis. Such studies are instrumental in elucidating the molecular underpinnings of vascular diseases and in identifying targets for therapeutic intervention in conditions like atherosclerosis and sepsis, where endothelial dysfunction plays a central role.

Signal Transduction Pathway Analysis: As a highly selective PAR-1 agonist, TFLLR-NH2(TFA) is invaluable for mapping intracellular signaling networks activated downstream of PAR-1 engagement. Researchers utilize it to stimulate specific pathways, such as MAPK, PI3K/Akt, and calcium mobilization, in a variety of cell types including smooth muscle cells, fibroblasts, and immune cells. This targeted approach enables the identification of key mediators and regulatory nodes within these pathways, advancing our understanding of how PAR-1 signaling influences cellular proliferation, migration, and gene expression in physiological and pathological contexts.

Pharmacological Screening and Drug Discovery: The ability of TFLLR-NH2(TFA) to selectively activate PAR-1 makes it a preferred tool in high-throughput screening assays designed to identify and characterize novel PAR-1 modulators. By providing a consistent and reproducible stimulus, it allows for the assessment of compound efficacy and specificity in inhibiting or potentiating PAR-1-mediated responses. This application is particularly valuable for pharmaceutical research focused on the development of targeted therapeutics for cardiovascular, inflammatory, and fibrotic diseases, where PAR-1 plays a critical role in disease progression.

Cellular Model Development: TFLLR-NH2(TFA) is frequently incorporated into experimental protocols to establish and validate cellular models of PAR-1 activation. By using this peptide to stimulate cells in vitro, researchers can create robust models that recapitulate key aspects of PAR-1-driven signaling and phenotypic changes. These models are essential for studying disease mechanisms, testing hypotheses regarding receptor function, and evaluating the impact of genetic or pharmacological interventions on PAR-1 activity. The reproducibility and specificity offered by TFLLR-NH2(TFA) make it an indispensable reagent for generating reliable data in basic and translational research settings.

Overall, the versatility of TFLLR-NH2(TFA) as a research tool is underscored by its broad applicability across multiple domains of cell biology and pharmacology. Its use in platelet activation studies, vascular endothelial research, signal transduction analysis, drug discovery, and cellular model development highlights its value in advancing scientific knowledge of PAR-1-mediated processes. By enabling precise and selective activation of PAR-1, this peptide supports the detailed dissection of complex biological pathways, ultimately contributing to a deeper understanding of cellular communication and disease mechanisms.

1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Spatiotemporal delivery of nanoformulated liraglutide for cardiac regeneration after myocardial infarction

4. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

5. The spatiotemporal control of signalling and trafficking of the GLP-1R